Celltrion Pharm, Inc.
068760.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
358
Cost of Revenue
267
Gross Profit
92
Gross Margin
25.5%
Operating Income
28
Operating Margin
7.8%
Net Income
16
Net Margin
4.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
43
EBITDA Margin
12.0%
2023
12/31/2023
Revenue
292
Cost of Revenue
202
Gross Profit
90
Gross Margin
30.8%
Operating Income
27
Operating Margin
9.3%
Net Income
16
Net Margin
5.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
41
EBITDA Margin
13.9%
2022
12/31/2022
Revenue
290
Cost of Revenue
206
Gross Profit
84
Gross Margin
28.9%
Operating Income
29
Operating Margin
9.9%
Net Income
19
Net Margin
6.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
41
EBITDA Margin
14.0%
2021
12/31/2021
Revenue
299
Cost of Revenue
210
Gross Profit
89
Gross Margin
29.7%
Operating Income
36
Operating Margin
12.0%
Net Income
26
Net Margin
8.7%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
48
EBITDA Margin
16.1%
2020
12/31/2020
Revenue
175
Cost of Revenue
121
Gross Profit
54
Gross Margin
30.7%
Operating Income
18
Operating Margin
10.1%
Net Income
16
Net Margin
9.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
29
EBITDA Margin
16.3%